Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-28 | Vaxart, Inc. | Tucker Sean
(SVP, Chief Scientific Officer) |
F | Common Stock | D | 3902 | $1.30 - $1.30 | $5,072 |
2024-03-28 | Vaxart, Inc. | Cummings James F.
(Chief Medical Officer) |
F | Common Stock | D | 3292 | $1.30 - $1.30 | $4,279 |
2023-03-28 | Vaxart, Inc. | Tucker Sean
(SVP, Chief Scientific Officer) |
F | Common Stock | D | 47191 | $0.71 - $1.20 | $38,170 |
2024-03-18 | Vaxart, Inc. | Tucker Sean
(SVP, Chief Scientific Officer) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
2023-12-08 | Vaxart, Inc. | Lee Phillip E
(Chief Financial Officer) |
F | Common Stock | D | 41094 | $0.63 - $0.71 | $28,701 |
2024-03-18 | Vaxart, Inc. | Lee Phillip E
(Chief Financial Officer) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
2023-12-08 | Vaxart, Inc. | Cummings James F.
(Chief Medical Officer) |
F | Common Stock | D | 39374 | $0.71 - $1.20 | $31,858 |
2024-03-18 | Vaxart, Inc. | Cummings James F.
(Chief Medical Officer) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
2023-12-08 | Vaxart, Inc. | Berg Edward B
(SVP, General Counsel) |
F | Common Stock | D | 42972 | $0.71 - $1.20 | $35,027 |
2024-03-18 | Vaxart, Inc. | Berg Edward B
(SVP, General Counsel) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
2024-03-18 | Vaxart, Inc. | Lo Steven
(President, Chief Exec Officer) |
A | Common Stock | A | 250000 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |